Free Trial

Andlauer Healthcare Group (TSE:AND) PT Lowered to C$43.00 at Scotiabank

Andlauer Healthcare Group logo with Industrials background

Andlauer Healthcare Group (TSE:AND - Free Report) had its price target trimmed by Scotiabank to C$43.00 in a report published on Thursday, Stock Target Advisor reports.

Several other research firms have also issued reports on AND. Royal Bank of Canada increased their price target on shares of Andlauer Healthcare Group from C$41.00 to C$42.00 and gave the stock a sector perform rating in a research report on Friday, August 2nd. TD Securities raised their price objective on shares of Andlauer Healthcare Group from C$52.00 to C$53.00 and gave the stock a buy rating in a report on Friday, August 2nd. Finally, Eight Capital lowered their price target on Andlauer Healthcare Group from C$58.00 to C$51.00 and set a buy rating on the stock in a research report on Friday, August 2nd. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of Moderate Buy and an average price target of C$48.29.

Check Out Our Latest Stock Analysis on Andlauer Healthcare Group

Andlauer Healthcare Group Stock Performance

Shares of Andlauer Healthcare Group stock traded down C$0.04 during trading hours on Thursday, hitting C$38.56. 6,863 shares of the company were exchanged, compared to its average volume of 31,086. The company has a current ratio of 1.35, a quick ratio of 1.66 and a debt-to-equity ratio of 41.86. The stock has a market capitalization of C$721.07 million, a price-to-earnings ratio of 25.61 and a beta of 0.66. Andlauer Healthcare Group has a 1 year low of C$36.43 and a 1 year high of C$44.12. The business has a 50-day moving average of C$39.24 and a 200-day moving average of C$39.79.

Andlauer Healthcare Group (TSE:AND - Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The company reported C$0.38 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of C$0.42 by C($0.04). Andlauer Healthcare Group had a net margin of 9.96% and a return on equity of 14.91%. The firm had revenue of C$161.45 million for the quarter, compared to analysts' expectations of C$165.00 million. As a group, analysts expect that Andlauer Healthcare Group will post 1.9331337 EPS for the current fiscal year.

Andlauer Healthcare Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Friday, September 27th will be issued a dividend of $0.11 per share. The ex-dividend date is Friday, September 27th. This represents a $0.44 dividend on an annualized basis and a yield of 1.14%. This is a positive change from Andlauer Healthcare Group's previous quarterly dividend of $0.10. Andlauer Healthcare Group's dividend payout ratio is currently 26.32%.

About Andlauer Healthcare Group

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

See Also

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

→ Election rigged? We caught them red-handed… (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Andlauer Healthcare Group right now?

Before you consider Andlauer Healthcare Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Andlauer Healthcare Group wasn't on the list.

While Andlauer Healthcare Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
Build-to-Order: The Strategy Fueling Toll Brothers’ Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines